KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Return on Equity: 2011-2025

Historic Return on Equity for Neogenomics (NEO) over the last 12 years, with Sep 2025 value amounting to -0.13%.

  • Neogenomics' Return on Equity fell 5.00% to -0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.13%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.09% for FY2024, which is 1.00% up from last year.
  • Neogenomics' Return on Equity amounted to -0.13% in Q3 2025, which was down 12.28% from -0.12% recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Return on Equity ranged from a high of 0.07% in Q2 2021 and a low of -0.16% during Q3 2022.
  • Its 3-year average for Return on Equity is -0.10%, with a median of -0.09% in 2023.
  • In the last 5 years, Neogenomics' Return on Equity climbed by 8bps in 2021 and then fell by 21bps in 2022.
  • Neogenomics' Return on Equity (Quarterly) stood at -0.01% in 2021, then fell by 14bps to -0.14% in 2022, then increased by 5bps to -0.09% in 2023, then grew by 1bps to -0.09% in 2024, then declined by 5bps to -0.13% in 2025.
  • Its last three reported values are -0.13% in Q3 2025, -0.12% for Q2 2025, and -0.09% during Q1 2025.